Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Long-Term Deferred Tax (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Long-Term Deferred Tax data on record, last reported at $267.9 million in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax fell 18.34% year-over-year to $267.9 million; the TTM value through Sep 2025 reached $267.9 million, down 18.34%, while the annual FY2024 figure was $314.5 million, 9.06% down from the prior year.
  • Long-Term Deferred Tax reached $267.9 million in Q3 2025 per AHCO's latest filing, down from $302.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $345.9 million in Q4 2023 and bottomed at $267.9 million in Q3 2025.
  • Average Long-Term Deferred Tax over 5 years is $305.6 million, with a median of $303.6 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 749.17% in 2021, then decreased 18.34% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $304.2 million in 2021, then decreased by 7.37% to $281.8 million in 2022, then increased by 22.74% to $345.9 million in 2023, then decreased by 9.06% to $314.5 million in 2024, then dropped by 14.81% to $267.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $267.9 million in Q3 2025, $302.2 million in Q2 2025, and $315.1 million in Q1 2025.